IMPEL PHARMACEUTICALS INC (IMPL) has 8 open-market insider trades by 7 insiders since 2021. The most active filer is Vivo Capital Surplus Fund VIII, L.P., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Henry R. Kravis | 10% Owner | — | 1 | $16.5M | 2021-04-27 |
| Jon Erik Kossow | 10% Owner | — | 1 | $12.4M | 2021-04-27 |
| Vivo Capital Surplus Fund VIII, L.P. via Hongbo Lu | 10% Owner | — | 2 | $8.7M | 2023-12-19 |
| Kush Parmar | 10% Owner | — | 1 | $8.6M | 2021-04-27 |
| venBio Global Strategic Fund II L.P. | 10% Owner | — | 1 | $6.8M | 2021-04-27 |
| Adrian Adams | CEOChairmanPres | — | 1 | $517K | 2021-08-18 |
| Timothy S. Nelson | Dir | — | 1 | $108K | 2021-11-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Vivo Capital Surplus Fund VIII, L.P. | 10% | Sell | $74K | 2023-12-15 |
| Timothy S. Nelson | Director | Buy | $108K | 2021-11-19 |
| Adrian Adams | CEO & Chairman +1 | Buy | $517K | 2021-08-18 |
| Vivo Capital Surplus Fund VIII, L.P. | 10% Owner | Buy | $8.6M | 2021-04-27 |
| Jon Erik Kossow | 10% Owner | Buy | $12.4M | 2021-04-27 |
| venBio Global Strategic Fund II L.P. | 10% Owner | Buy | $6.8M |
Companies that share insiders with IMPL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-04-27 |
| Henry R. Kravis | 10% Owner | Buy | $16.5M | 2021-04-27 |